"Quick Analysis" above starts the Research Desk from this K-line and runs one quick pass: three analyst lenses (macro, fundamentals, technicals) plus a trade plan and risk statistics, usually in about 30 s and up to 5 minutes when upstream is slow. For the five-team deep research and the institutional report, switch the mode to Deep inside the Research Desk.
1-YEAR PRICE
One-Year Trajectory
RISK-ON252 BARS · +18.6% YOY
2025-10-30$76.69 → $90.93 (+18.6%)2026-10-30
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Smart Money
Loading § Smart Money
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE. Sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). Server-rendered values are cached for up to 60 minutes via ISR; the quote refreshes in your browser.
VALUATION
Valuation (SEC EDGAR + Finnhub)
RISK-ONDCF FV $153.40 · +68.7% VS SPOT
DCF Fair Value
$153.40
DCF vs Spot
+68.7%
Comps Fair Value
—
WACC Used
+7.3%
Terminal g
+2.5%
Verdict: strong-buy · DCF $153.40 (+68.7%) · method: DCF only
⚠ Cohort refused: only 0 of 0 candidate peers are Health Care names of comparable size (within a 40x market-cap band), below the minimum of 4 — a median of 0 is not a comparables set.
FINANCIALS
Multi-Year Financials (SEC XBRL)
CALMYOY REV +7.8% · 4 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$402.07B
$1.77B
$10.64B
$7.81B
$253.54B
2024-12
$372.81B
$4.61B
$9.11B
$6.33B
$253.22B
2023-12
$357.78B
$8.34B
$13.43B
$10.39B
$249.73B
2022-12
$322.47B
$4.31B
$16.18B
$13.45B
$228.28B
SMART MONEY
CVS — Who Is Buying
—NO TRACKED HOLDERS THIS QUARTER · 0 MEMBERS
No smart-money filings for CVS right now: none of the filers we track disclosed a position this quarter, and no member of Congress disclosed a trade.
Congressional disclosures
No member of Congress has filed a disclosed trade in this stock. The STOCK Act covers US-listed securities only, and filings arrive 30-45 days after the trade.
Last updated 2026-10-30 · Sources: SEC EDGAR 13F and US Congress STOCK Act disclosures Not investment advice. 13Fs are quarterly and land up to 45 days after the quarter ends; Congressional disclosures are also up to 45 days late and report a value RANGE, never an exact amount.